Gilead Sciences Aktie - GIS

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

91,92

Gebot

91,80

Fragen

92,02

Volumen

1.645

91,22 Tagesbereich 92,98

57,18 52-Wochen-Bereich 112,18

Marktkapitalisierung

114,472B

Handelsende

92,10

Handelsbeginn

92,83

Letzte Trade

91.99

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

5.739

Ausgegebene Aktien

1.245.346.062

Dividendenrendite

3.91%

Kurs-Gewinn-Verhältnis

271,25

Gewinn pro Aktie (EPS)

0,39

Erlöse

28,75B

Nettogewinn

480M

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.gilead.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Gilead Sciences Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker GIS. The last closing price for Gilead Sciences was 92,10 €. Over the last year, Gilead Sciences shares have traded in a share price range of 57,18 € to 112,18 €.

Gilead Sciences currently has 1.245.346.062 shares in issue. The market capitalisation of Gilead Sciences is 114,70 € billion. Gilead Sciences has a price to earnings ratio (PE ratio) of 271.25.

Gilead and Genesis team up on using AI to develop novel therapeutics

Gilead Sciences Inc on Tuesday announced a strategic collaboration with Genesis Therapeutics Inc to discover and deve ...

Gilead notes transfer of Yescarta marketing authorisation from Daiichi

Gilead Sciences Inc on Thursday said that the marketing authorisation in Japan for its chimeric antigen receptor T-ce ...

GLOBAL BUSINESS: Bristol-Myers wins approval for Breyanzi in Japan

The following is a round-up of updates by global companies, issued on Tuesday and not separately reported by Alliance ...

World Health Organisation 'strongly recommends' Pfizer's covid pill

The World Health Organization said Friday it "strongly recommended" Pfizer Inc's covid-19 antiviral pill Paxlovid for ...

TOP NEWS: GSK's ViiV gets USD1.25 billion from Gilead patent pact

GlaxoSmithKline PLC on Wednesday said majority-owned investee ViiV Healthcare has agreed to settle a global patent in ...

Gilead Sciences receives expedited approval for antiviral drug Veklury

Gilead Sciences Inc on Friday said that the US Food & Drug Administration granted its Veklury drug expedited approval ...

Gilead and Merck & Co HIV double drug combo starts Phase 2 study

Gilead Sciences Inc and Merck & Co Inc announced Tuesday the start of a Phase 2 clinical study evaluating an investig ...

Gilead Sciences Teams Up With Vir To Develop Chronic Hepatitis B Cure

Gilead Sciences Inc on Tuesday said it has entered into a clinical collaboration with Vir Biotechnology Inc focused o ...

Gilead Sciences Ups Annual Guidance As Covid-19 Drug Boosts Sales

Gilead Sciences Inc on Monday said it has increased its product sales guidance for 2020 as one of its drugs used to t ...

Gilead's Kite, Oxford BioTherapeutics Partner On Cell Therapy Research

Kite, a Gilead Sciences Inc portfolio company, on Wednesday said it and Oxford BioTherapeutics Ltd have entered into ...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-4.34	-4.50862248078	96.26	96.75	87.4	3051	93.04210319	DE
4	-6.48	-6.58536585366	98.4	104.24	87.4	5157	97.78040854	DE
12	2.58	2.88784419073	89.34	112.18	85.37	5739	99.5416256	DE
26	12.100001	15.1591094357	79.819999	112.18	78.959999	5747	92.84868329	DE
52	28.52	44.9842271293	63.4	112.18	57.18	5193	80.6329961	DE
156	34.33	59.611043584	57.59	112.18	54.55	4432	75.59129767	DE
260	8.46	10.1365923796	83.46	112.18	46.165	8608	66.47770894	DE

GIS - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences share price?

The current share price of Gilead Sciences is 91,92 €

How many Gilead Sciences shares are in issue?

Gilead Sciences has 1.245.346.062 shares in issue

What is the market cap of Gilead Sciences?

The market capitalisation of Gilead Sciences is EUR 114,7B

What is the 1 year trading range for Gilead Sciences share price?

Gilead Sciences has traded in the range of 57,18 € to 112,18 € during the past year

What is the PE ratio of Gilead Sciences?

The price to earnings ratio of Gilead Sciences is 271,25

What is the cash to sales ratio of Gilead Sciences?

The cash to sales ratio of Gilead Sciences is 4,53

What is the reporting currency for Gilead Sciences?

Gilead Sciences reports financial results in USD

What is the latest annual turnover for Gilead Sciences?

The latest annual turnover of Gilead Sciences is USD 28,75B

What is the latest annual profit for Gilead Sciences?

The latest annual profit of Gilead Sciences is USD 480M

What is the registered address of Gilead Sciences?

The registered address for Gilead Sciences is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Gilead Sciences website address?

The website address for Gilead Sciences is www.gilead.com

Which industry sector does Gilead Sciences operate in?

Gilead Sciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
AZK0Hertz Global Holdings Inc	7,27 € (45,40%)	366,15k
601AAmmPower Corp	0,0215 € (43,33%)	18,51k
DPMSumitomo Pharma Co. Ltd.	4,50 € (43,31%)	7,6k
UQ1Uniqure NV	11,25 € (36,26%)	7,73k
F1BLhyfe SA	4,225 € (35,42%)	282
013CJDcom Inc	15,378 € (0,00%)	0
013AJD.com Inc	30,55 € (0,00%)	0
0110Thesis Gold Inc	0,606 € (0,00%)	0
00WAspermont Ltd	0,0025 € (0,00%)	0
000Greenvolt Energias Renovaveis SA	0,00 € (0,00%)	0
013CJDcom Inc	15,378 € (0,00%)	0
013AJD.com Inc	30,55 € (0,00%)	0
0110Thesis Gold Inc	0,606 € (0,00%)	0
00WAspermont Ltd	0,0025 € (0,00%)	0
000Greenvolt Energias Renovaveis SA	0,00 € (0,00%)	0

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Gilead Sciences Inc (GIS)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Gilead Sciences Inc

GIS Neueste Nachrichten

Gilead and Genesis team up on using AI to develop novel therapeutics

Gilead notes transfer of Yescarta marketing authorisation from Daiichi

GLOBAL BUSINESS: Bristol-Myers wins approval for Breyanzi in Japan

World Health Organisation 'strongly recommends' Pfizer's covid pill

TOP NEWS: GSK's ViiV gets USD1.25 billion from Gilead patent pact

Gilead Sciences receives expedited approval for antiviral drug Veklury

Gilead and Merck & Co HIV double drug combo starts Phase 2 study

Gilead Sciences Teams Up With Vir To Develop Chronic Hepatitis B Cure

Gilead Sciences Ups Annual Guidance As Covid-19 Drug Boosts Sales

Gilead's Kite, Oxford BioTherapeutics Partner On Cell Therapy Research

GIS - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Gilead Sciences Inc (GIS) Börsenkurse

Gilead Sciences Inc (GIS)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Gilead Sciences Inc

GIS Neueste Nachrichten

Gilead and Genesis team up on using AI to develop novel therapeutics

Gilead notes transfer of Yescarta marketing authorisation from Daiichi

GLOBAL BUSINESS: Bristol-Myers wins approval for Breyanzi in Japan

World Health Organisation 'strongly recommends' Pfizer's covid pill

TOP NEWS: GSK's ViiV gets USD1.25 billion from Gilead patent pact

Gilead Sciences receives expedited approval for antiviral drug Veklury

Gilead and Merck & Co HIV double drug combo starts Phase 2 study

Gilead Sciences Teams Up With Vir To Develop Chronic Hepatitis B Cure

Gilead Sciences Ups Annual Guidance As Covid-19 Drug Boosts Sales

Gilead's Kite, Oxford BioTherapeutics Partner On Cell Therapy Research

GIS - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen